<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kohno D</submitter><funding>BINDS</funding><funding>MEXT | Japan Society for the Promotion of Science (JSPS)</funding><funding>Wellcome Trust</funding><pagination>4919-4961</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12436618</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(18)</volume><pubmed_abstract>N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) is an abundant chemical RNA modification involved in the regulation of many biological processes. The m&lt;sup>6&lt;/sup>A demethylase FTO (fat mass and obesity-associated protein) is known to affect body weight, but its systemic context and underlying mechanisms remain unclear. Here, we found that mice lacking or overexpressing Fto in agouti-related peptide-expressing (AgRP) neurons in the hypothalamus exhibited decreased and increased body weight, respectively. FTO demethylated m&lt;sup>6&lt;/sup>A on mRNAs for proteins associated with membrane trafficking and alternative splicing in AgRP neurons. Downstream, FTO-modulated alternative splicing of the axonal motor protein Kif1a affected its hinge region, which is relevant to the structure and function of KIF1A. Notably, Kif1a knockdown in AgRP neurons suppressed the weight gain of mice overexpressing Fto. In addition, FTO increased the trafficking and secretion of dense-core vesicles containing neuropeptides NPY and AgRP from AgRP neurons. Collectively, these results reveal a novel regulatory FTO-KIF1A axis in the brain affecting appetite-stimulating AgRP neurons and systemic energy homeostasis, via FTO regulation of the epitranscriptome of AgRP neurons.</pubmed_abstract><journal>The EMBO journal</journal><pubmed_title>FTO promotes weight gain via altering Kif1a splicing and axonal vesicle trafficking in AgRP neurons.</pubmed_title><pmcid>PMC12436618</pmcid><funding_grant_id>JPMXS0420600120</funding_grant_id><funding_grant_id>17K08566</funding_grant_id><funding_grant_id>JP21am0101120</funding_grant_id><funding_grant_id>New Paradigms - Establishing Centres for Fostering Medical Researchers of the Future programs</funding_grant_id><funding_grant_id>the Promotion Plan for the Platform of Human Resource Development for Cancer</funding_grant_id><funding_grant_id>the Fostering Health Professionals for Changing Needs of Cancer</funding_grant_id><funding_grant_id>23K21617</funding_grant_id><funding_grant_id>25K03043</funding_grant_id><funding_grant_id>21H03349</funding_grant_id><funding_grant_id>25870666</funding_grant_id><funding_grant_id>JP24wm0625103</funding_grant_id><pubmed_authors>Hirai H</pubmed_authors><pubmed_authors>Kobayashi R</pubmed_authors><pubmed_authors>Kohno D</pubmed_authors><pubmed_authors>Yoshikawa C</pubmed_authors><pubmed_authors>Hatada I</pubmed_authors><pubmed_authors>Ohashi K</pubmed_authors><pubmed_authors>Sasaki T</pubmed_authors><pubmed_authors>Ariyani W</pubmed_authors><pubmed_authors>Yokota-Hashimoto H</pubmed_authors><pubmed_authors>Matsui S</pubmed_authors><pubmed_authors>Suyama S</pubmed_authors><pubmed_authors>Sadakata T</pubmed_authors><pubmed_authors>Susanti VY</pubmed_authors><pubmed_authors>Konno A</pubmed_authors><pubmed_authors>Tsuneoka H</pubmed_authors><pubmed_authors>Ichinose S</pubmed_authors><pubmed_authors>Kitamura T</pubmed_authors><pubmed_authors>Harada A</pubmed_authors><pubmed_authors>Nishiyama M</pubmed_authors><pubmed_authors>Kawabata-Iwakawa R</pubmed_authors><pubmed_authors>Yada T</pubmed_authors><pubmed_authors>Horii T</pubmed_authors></additional><is_claimable>false</is_claimable><name>FTO promotes weight gain via altering Kif1a splicing and axonal vesicle trafficking in AgRP neurons.</name><description>N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) is an abundant chemical RNA modification involved in the regulation of many biological processes. The m&lt;sup>6&lt;/sup>A demethylase FTO (fat mass and obesity-associated protein) is known to affect body weight, but its systemic context and underlying mechanisms remain unclear. Here, we found that mice lacking or overexpressing Fto in agouti-related peptide-expressing (AgRP) neurons in the hypothalamus exhibited decreased and increased body weight, respectively. FTO demethylated m&lt;sup>6&lt;/sup>A on mRNAs for proteins associated with membrane trafficking and alternative splicing in AgRP neurons. Downstream, FTO-modulated alternative splicing of the axonal motor protein Kif1a affected its hinge region, which is relevant to the structure and function of KIF1A. Notably, Kif1a knockdown in AgRP neurons suppressed the weight gain of mice overexpressing Fto. In addition, FTO increased the trafficking and secretion of dense-core vesicles containing neuropeptides NPY and AgRP from AgRP neurons. Collectively, these results reveal a novel regulatory FTO-KIF1A axis in the brain affecting appetite-stimulating AgRP neurons and systemic energy homeostasis, via FTO regulation of the epitranscriptome of AgRP neurons.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-04-08T19:53:57.638Z</modification><creation>2026-04-08T14:36:14.986Z</creation></dates><accession>S-EPMC12436618</accession><cross_references><pubmed>40634669</pubmed><doi>10.1038/s44318-025-00503-3</doi></cross_references></HashMap>